Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
20 Pages - GLDATA51005
$250.00

Summary

Gulf Pharmaceutical Industries P.S.C. (Julphar) is a pharmaceutical company which undertakes the manufacture and distribution of medicines. It is one of the largest pharmaceutical distributors in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, cough and cold preparations, ulcer-healing agents, cardiovascular products, biotech, dermatology, insulin, over-the-counter, GIT, metabolic and paramedical products, women’s health, pulmonary, wound and burn, and other products. The company has manufacturing facilities in Ras Al Khaimah and Ethiopia. It has direct offices in Asia, Middle East and Africa. Julphar has 40 gloal offices and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries P.S.C. (JULPHAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Gulf Pharmaceutical Industries P.S.C., Medical Devices Deals, 2010 to YTD 2016 9
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MSD Enters Into Distribution Agreement With Julphar 11
Julphar Forms Joint Venture With Cigalah 12
Licensing Agreements 13
Gulf Pharma Enters into Licensing Agreement with MSD 13
BMG Pharma Enters Into Licensing Agreement With Julphar For Ginoxil 14
Acquisition 15
Julphar Acquires 77.5% Stake in RAK Pharma for USD9.5 Million 15
Gulf Pharmaceutical Industries P.S.C. - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Gulf Pharmaceutical Industries P.S.C., Deals By Therapy Area, 2010 to YTD 2016 8
Gulf Pharmaceutical Industries P.S.C., Medical Devices Deals, 2010 to YTD 2016 9
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
MSD Enters Into Distribution Agreement With Julphar 11
Julphar Forms Joint Venture With Cigalah 12
Gulf Pharma Enters into Licensing Agreement with MSD 13
BMG Pharma Enters Into Licensing Agreement With Julphar For Ginoxil 14
Julphar Acquires 77.5% Stake in RAK Pharma for USD9.5 Million 15
Gulf Pharmaceutical Industries P.S.C., Key Competitors 16
Gulf Pharmaceutical Industries P.S.C., Key Employees 17
Gulf Pharmaceutical Industries P.S.C., Other Locations 18
Gulf Pharmaceutical Industries P.S.C., Subsidiaries 18

List of Figures
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Gulf Pharmaceutical Industries P.S.C., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Gulf Pharmaceutical Industries P.S.C., Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838